PATENTS - Criteria for patent protection - Non-obviousness
Appeal by Teva Canada Limited (Teva) and cross-appeal by Janssen Inc. and Janssen Pharmaceutica NV (Janssen) from Federal Court judgment for patent infringement. Teva argued that the Federal Court made reviewable...To view the full article, register now.
Already a subscriber? Click here to view full article